Press and Public Relations

Press and Public Relations

Press Officer and Head of Press and Public Relations (in ch.)

Dr. Sibylle Kohlstädt

Im Neuenheimer Feld 280
69120 Heidelberg

Phone: +49 6221 422854
Fax: +49 6221 422968


Recent Press Releases

No. 19 | 20. March 2018 | by Koh

Ten years of successful research on cancer stem cells – Start of the third funding period

Dietmar Hopp (right) visiting the HI-STEM labs. Hopp is accompanied by DKFZ...
© Jutta Jung/DKFZ

HI-STEM, the Heidelberg Institute for Stem Cell Technology and Experimental Medicine at the German Cancer Research Center (DKFZ), is looking back on ten successful years. In numerous types of cancer, HI-STEM researchers have been able to show the role of stem cells in the development, spread and therapy resistance of malignant tumors. The results show new approaches towards treating the threatening diseases more specifically and more effectively in the future. HI-STEM, a nonprofit institute, will now receive support amounting to €7.5 million from the Dietmar Hopp Foundation for the third consecutive five-year funding period. In addition, the Dietmar Hopp Foundation has agreed to support another two research projects at HI-STEM with funds amounting to €2.25 million.

learn more

No. 18 | 15. March 2018 | by Koh

Diabetes: Are high blood glucose levels an effect rather than the cause of the disease?

Flies are an established model to study energy metabolism. The body fat of ...
© Teleman/DKFZ

Insulin resistance and elevated blood glucose levels are considered to be the cause of type 2 diabetes. However, scientists from the German Cancer Research Center (DKFZ) and Heidelberg University Hospital have now provided evidence that things might be completely different. They showed in flies that elevated levels of the metabolite MG (methylglyoxal) cause the typical diabetic disturbances of the metabolism and lead to insulin resistance, obesity and elevated blood sugar levels.

learn more

No. 17c | 12. March 2018

Combination therapy in neuroblastoma: It`s all about the mix

Can neuroblastomas be treated more effectively using a mixture of two activ...
© Philipp Benjamin, KiTZ

The combination of two cell division inhibitors causes malignant nervous system tumors to die off, as scientists from the "Hopp Children's Cancer Center at the NCT Heidelberg" (KiTZ) have shown in experimental studies.The combination strategy could be the key to new targeted therapies against this aggressive type of tumor.
The Hopp Children's Cancer Center at the NCT Heidelberg (KiTZ) is a joint institution of Heidelberg University Hospital and the German Cancer Research Center (DKFZ).

learn more


einblick (in German only)


Subscribe to our RSS-Feed.

to top